Brief: Mankind Pharma Buys Remaining 10% Stake In Upakarma
02/06/2026 13:35
BRIEF-Mankind Pharma Buys Remaining 10% Stake In Upakarma June 2 (Reuters) - Mankind Pharma Ltd MNKI.NS:
UNIT BUYS REMAINING 10% STAKE IN UPAKARMA
ACQUISITION COST FOR 10% STAKE IN UPAKARMA IS 7.5 MILLION RUPEES
Source text: ID:nBSE97jdLy
Further company coverage: MNKI.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mankind Pharma
See all newsBrief: Mankind Pharma Buys Remaining 10% Stake In Upakarma
India's top condom maker may hike prices on war-linked oil surge
India's Mankind Pharma climbs on strong Q4 profit
Indian drugmaker Mankind posts strong quarterly profit on demand for chronic therapies
Brief: Mankind Pharma March-Quarter Consol Profit From Continuing Operations 5.59 Billion Rupees